• A picture of a medicine capsule containing DNA
    A capsule of DNA

    Gene therapy is a term used to describe the delivery of nucleic acid polymers (either DNA or RNA) into a patient’s cells as a drug to treat disease, including the replacement of a mutated gene with functional copy.

    Gene therapies can be delivered by a number of different mechanisms (Figure 1) and introduced into either somatic (body) cells where the effect is not passed onto the children or into the gametes (sperm or egg cells) where the effect is heritable. We have also included a of Figure 1 in the downloads section below in case you find this figure difficult to read.

    Gene augmentation therapy diagram

    Figure 1: Gene therapy techniques © St George’s, University of London

    In order to get the therapeutic section of / / into the cell, a vehicle or vector is required. Commonly used vectors include viruses, bacteria or plasmids. The vector carries the nucleic acids across the cell membrane, cytoplasm and into the nucleus of the cell. Once inside the nucleus, the new nucleic acids may replace the function of a mutated gene, inhibit production of a gene / protein or target sub-groups of cells for destruction (Figure 1).

    For many years gene therapy has promised to transform the management of patients with genetic diseases but, sadly, consistent, reliable gene therapies remain elusive. This failure of gene therapies to become a mainstay of treatment is due to a number of different factors:

    • It can be challenging to ensure the nucleic acids reach the right cell at the right time. If a new gene reaches the wrong cell not only will the therapy fail but it may cause serious side effects.
    • The new nucleic acids may be recognised by the body’s defence mechanism as foreign and be destroyed. As well as eliminating the therapeutic vector, the triggered immune response may cause serious clinical problems for the patient.
    • It is difficult to ensure that newly introduced nucleic acids only interfere with the mutated gene and not other, normally functioning, genes.
    • So far, gene therapy is enormously expensive.

    Although, because of these challenges, gene therapy remains a largely experimental technique, there have been some successes including the treatment of X linked severe combined immune deficiency (SCID).

     
     

    No comments

    Be the first one to leave a comment.

    Post a Comment


     

     

    Latest Posts

    Latest Video

     
     

    LATEST POSTS

    Health Benefits Associated With Drinking Water

      Out all the things that we eat and drink, water stands out as the most important one. When you drink water the body is…

    Artificial Intelligence Diagnoses Heart Murmurs Better Than Expert Cardiologists

    SOURCE Eko’s heart murmur detection algorithm outperformed four out of five cardiologists for the detection of heart murmurs in a recent clinical study. The algorithm…

    UCI researchers uncover evidence of restored vision in rats following cell transplant

    Irvine, Calif. – November 5, 2018 – Researchers from the University of California, Irvine School of Medicine, have discovered that neurons located in the vision centers…

    Artificial intelligence controls quantum computers

    SOURCE (Nanowerk News) Quantum computers could solve complex tasks that are beyond the capabilities of conventional computers. However, the quantum states are extremely sensitive to…

    Bad Oral Habits: How to Get Rid of These Awful Habits?

    You are practicing excellent dental care: brushing your teeth, floss regularly and visiting your dentist two times a year for cleanings and checkups. These things…

    Change the World: How to Get Your Medical Invention in Hospitals Today

    Medical advancements have completely changed the world. We now live longer, better lives, meaning our legacies and impact on this planet are greater than ever…

    profvest.com

    Сashbery hyip

    www.profvest.com